tiprankstipranks
Trending News
More News >
Brainsway (BRSYF)
:BRSYF
US Market

Brainsway (BRSYF) Earnings Dates, Call Summary & Reports

Compare
8 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0.02
Same Quarter Last Year
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 11, 2025
|
% Change Since: -27.81%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
BrainsWay's earnings call reflected a strong financial performance with significant revenue growth, increased system placements, and market expansion. Innovations in TMS treatments and a robust cash position further underscored positive prospects. However, there were some challenges with rising operating expenses and limited OCD coverage.
Company Guidance
During BrainsWay's fourth quarter and full year 2024 earnings call, the company reported several key metrics reflecting robust growth and strategic progress. The revenue for the fourth quarter reached $11.4 million, marking a 27% year-over-year increase, while the full year revenue was $41 million, showing a 29% increase from 2023. The company shipped 75 Deep TMS systems in Q4, a 25% increase from the same period last year, leading to a total installed base of 1,353 systems by year-end. Gross margin remained strong at 75% for both the fourth quarter and the full year. BrainsWay achieved a positive net income of $1.5 million for the quarter and $2.9 million for the full year, alongside positive adjusted EBITDA of $1.4 million for Q4 and $4.5 million for the year. Looking ahead, the company anticipates 2025 revenue in the range of $49 million to $51 million, representing growth of 20% to 24%, with expected operating income of 3% to 4% and adjusted EBITDA between 11% and 12%.
Strong Revenue Growth
BrainsWay generated $11.4 million in revenue in Q4 2024, marking a 27% year-over-year increase. For the full year, 2024 revenue reached $41 million, a 29% increase compared to 2023.
Increased System Placements
The company shipped 75 Deep TMS systems in Q4 2024, representing a 25% increase compared with the same period last year, and the total installed base reached 1,353 systems.
Positive Financial Performance
BrainsWay reported a gross margin of 75% for both Q4 and full year 2024, with positive net income for the fifth consecutive quarter and positive adjusted EBITDA for the sixth consecutive quarter.
Promising Market Expansion
The company expanded its market presence in key regions like Canada, Asia, India, and Europe, and saw increased sales for OCD treatment, the first TMS therapy approved for this condition.
Innovative Clinical Developments
Notable advancements include the FDA's decision to extend the age range for MDD treatment, and positive data on Deep TMS combined with psychedelic therapies for depression.
Robust Cash Position
BrainsWay ended 2024 with $69.4 million in cash, supported by a $20 million equity financing from Valor Equity Partners.
---

Brainsway (BRSYF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BRSYF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q1)
- / -
Mar 11, 20252024 (Q4)
- / 0.04
0.004886.67% (+0.04)
Nov 12, 20242024 (Q3)
- / 0.02
-0.007384.62% (+0.03)
Aug 06, 20242024 (Q2)
- / 0.02
-0.05136.61% (+0.07)
May 08, 20242024 (Q1)
- / <0.01
-0.07104.63% (+0.07)
Mar 06, 20242023 (Q4)
- / <0.01
-0.111103.68% (+0.11)
Nov 15, 20232023 (Q3)
- / >-0.01
-0.14194.99% (+0.13)
Aug 09, 20232023 (Q2)
- / -0.05
-0.06826.51% (+0.02)
May 17, 20232023 (Q1)
- / -0.07
-0.052-34.20% (-0.02)
Mar 15, 20232022 (Q4)
- / -0.11
-0.035-216.28% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

BRSYF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 11, 2025$4.71$4.90+4.03%
Nov 12, 2024$3.15$3.150.00%
Aug 06, 2024$2.10$2.100.00%
May 08, 2024$2.47$2.470.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Brainsway (BRSYF) report earnings?
Brainsway (BRSYF) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is Brainsway (BRSYF) earnings time?
    Brainsway (BRSYF) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BRSYF EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis